|
AU5782499A
|
|
Factor v leiden detection
|
|
AU5346299A
|
|
Du site-directed cleavage of covalent conjugates
|
|
US6171795B1
|
|
Nucleic acid ligands to CD40ligand
|
|
WO9952897A1
|
|
Novel reagents for use as coupling activators and coupling reagents in organic synthesis
|
|
US6120800A
|
|
Vinca-alkaloid vesicles with enhanced efficacy and tumor targeting properties
|
|
US6183967B1
|
|
Nucleic acid ligand inhibitors to DNA polymerases
|
|
WO9931276A1
|
|
Homogeneous detection of a target through nucleic acid ligand-ligand beacon interaction
|
|
US6020483A
|
|
Nucleoside modifications by palladium catalyzed methods
|
|
US6048698A
|
|
Parallel SELEX™
|
|
US5989823A
|
|
Homogeneous detection of a target through nucleic acid ligand-ligand beacon interaction
|
|
CA2303366A1
|
|
Liposomal camptothecin formulations
|
|
US6020206A
|
|
Homocysteine assay
|
|
US6001577A
|
|
Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
|
|
AU7813698A
|
|
Nucleic acid detection
|
|
US5958449A
|
|
Antibiotic formulation and use for bacterial infections
|
|
CA2315271A1
|
|
Platelet derived growth factor (pdgf) nucleic acid ligand complexes
|
|
US6124449A
|
|
High affinity TGFβ nucleic acid ligands and inhibitors
|
|
US6140490A
|
|
High affinity nucleic acid ligands of complement system proteins
|
|
AU5271198A
|
|
Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
|
|
AU6022798A
|
|
Bioconjugation of oligonucleotides
|
